Form 4: Outset Medical GC Executes Sell-to-Cover Transaction

General Counsel John L. Brottem sold 2,638 shares of Outset Medical common stock to satisfy tax withholding obligations.

Summary

• John L. Brottem, General Counsel of Outset Medical, Inc., sold 2,638 shares of common stock on May 15, 2026.
• The transaction was executed at a price of $3.70 per share.
• The sale was a mandatory 'sell-to-cover' transaction to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• The filing includes a correction to a previous Form 4 filed on February 19, 2026, regarding the number of shares sold for tax purposes.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a discretionary market move.

Positives

• The transaction was non-discretionary, indicating it was not a signal of management's view on the company's future performance.

Negatives

• The filing highlights an administrative error in a previous February 2026 filing, necessitating a correction.

Risks

• Administrative errors in regulatory filings can lead to increased scrutiny or potential compliance concerns.

Future Outlook

No forward-looking guidance or strategic outlook provided in this document.

Management Comments

• The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard corporate practice for executives to manage tax liabilities upon RSU vesting and generally do not reflect internal sentiment regarding company health.

Comparison to Industry Standards

• The use of sell-to-cover transactions is a standard industry practice for executive compensation management in the medical device sector.
• Administrative corrections to previous filings are common but reflect a need for improved internal controls.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Outset Medical, OM, Insider Trading, Form 4, Tax Withholding, General Counsel